These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 578017)

  • 21. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The importance of serum insulin determination in the diagnosis and treatment of diabetes mellitus (author's transl)].
    Willms B
    MMW Munch Med Wochenschr; 1975 Oct; 117(41):1643-8. PubMed ID: 810689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acid-base and hormonal abnormalities in dogs with naturally occurring diabetes mellitus.
    Durocher LL; Hinchcliff KW; DiBartola SP; Johnson SE
    J Am Vet Med Assoc; 2008 May; 232(9):1310-20. PubMed ID: 18447775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic relevance of 3-hour blood glucose value and serum insulin concentration in the oral glucose tolerance test].
    Haslbeck M; Pröls H; Löffler G; Mehnert H
    Verh Dtsch Ges Inn Med; 1975; 81():1497-501. PubMed ID: 1227006
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum, zinc, copper and insulin in diabetes mellitus.
    Mateo MC; Bustamante JB; Cantalapiedra MA
    Biomedicine; 1978 Apr; 29(2):56-8. PubMed ID: 667289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response of plasma insulin, serum free fatty acids and blood glucose in growth onset diabetics, to I.V. tolbutamide.
    Kirti S; Dutta PK; Vaishnava H; Singh RB
    J Assoc Physicians India; 1976 Mar; 24(3):141-6. PubMed ID: 1010812
    [No Abstract]   [Full Text] [Related]  

  • 28. [Improvement of glucose tolerance in diabetics under nicardipine therapy].
    Custro N; Scafidi V; Calanni S; Casiglia D
    Minerva Med; 1988 Feb; 79(2):123-6. PubMed ID: 3281062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Levels of Zn and Cu in the serum of a diabetic population].
    D'Ocon C; Alonso de Armiño V; Frasquet I
    Rev Esp Fisiol; 1987 Sep; 43(3):335-8. PubMed ID: 3321254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Raised glucagon levels of the blood induced by arginine: relation to blood sugar, blood insulin and STH in aged non-diabetics and diabetics].
    Ferrero E; Casale G; Tassi G; Ciaponi A
    Minerva Med; 1978 Apr; 69(18):1233-9. PubMed ID: 662151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
    Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
    Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin secretion during oral treatment with beta-adrenergic blocking agents in diabetics.
    Acta Diabetol Lat; 1976; 13(1-2):77-9. PubMed ID: 989658
    [No Abstract]   [Full Text] [Related]  

  • 33. Improvement of insulin secretion in diabetics by a prostaglandin synthesis inhibitor.
    Robertson RP; Chen M; McRae JR; Metz SA
    Adv Exp Med Biol; 1979; 119():227-31. PubMed ID: 495281
    [No Abstract]   [Full Text] [Related]  

  • 34. Insulin in protein fractions of serum from healthy people and from insulin-treated diabetics.
    RANDLE PJ; TAYLOR KW
    Lancet; 1958 Nov; 2(7054):996-7. PubMed ID: 13599463
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma insulin activity in diabetics.
    VALLANCE-OWEN J
    Postgrad Med J; 1959 May; 35(403):266-70. PubMed ID: 13657804
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies on lipocaic; effect of prolonged administration of lipocaic on glucose and lipase levels in the blood in diabetics].
    PEGNI U; BEFANI A
    Riv Crit Clin Med; 1952 Mar; 52(1-2):69-83. PubMed ID: 13056480
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum insulin-like activity in untreated diabetics.
    BEIGELMAN PM; TRANQUADA RE
    Diabetes; 1962; 11():179-82. PubMed ID: 13866622
    [No Abstract]   [Full Text] [Related]  

  • 38. [Blood glucose concentration and insulin activity in serum after administration of the beta receptor blockader nifenalol-HC1 (INPEA). Studies in metabolically healthy people and diabetics].
    Rabast U; Kasper H; Schönborn J; Knechtel B
    Ther Ggw; 1977 Jun; 116(6):1162-74. PubMed ID: 578017
    [No Abstract]   [Full Text] [Related]  

  • 39. [Influence of the beta-receptor blocker nifenalol on insulin secretion in normal subjects and diabetic patients (author's transl)].
    Hasslacher C; Wahl P; Riemer G
    Arzneimittelforschung; 1977 Feb; 27(2):426-9. PubMed ID: 577165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor.
    Robertson RP; Porte D
    J Clin Invest; 1973 Apr; 52(4):870-6. PubMed ID: 4693651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.